Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

CME

CME Group Reports Record Q1 Revenue

CME Group Inc. has reported all-time record revenue, adjusted operating income, adjusted net income, and adjusted earnings per share for the first quarter of 2025. The company's revenue stood at $1.6 billion, marking a 10% increase from the first quarter of 2024.

The average daily volume (ADV) also reached a new high at 29.8 million contracts, with growth observed in every asset class. Commodities grew by 19%, financials increased by 12%, and ADV outside the U.S. reached a new high of 8.8 million contracts, representing a 19% increase year over year.

Clearing and transaction fees revenue for the first quarter of 2025 totaled $1.3 billion, and the total average rate per contract was $0.686. Market data revenue for the same period amounted to $195 million.

As of March 31, 2025, the company had $1.6 billion in cash (including $200 million deposited with Fixed Income Clearing Corporation) and $3.4 billion of debt. During the first quarter, the company paid dividends of approximately $2.6 billion, bringing the total amount returned to shareholders in the form of dividends since early 2012 to $28.6 billion.

CME Group will hold a Q&A conference call to discuss the first-quarter 2025 results. The company's exchanges offer a wide range of global benchmark products across major asset classes, enabling clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data. Today the company's shares have moved -2.3% to a price of $259.36. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS